Literature DB >> 23065151

Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome.

Nicholas T Funderburg1, David A Zidar, Carey Shive, Anthony Lioi, Joseph Mudd, Laura W Musselwhite, Daniel I Simon, Marco A Costa, Benigno Rodriguez, Scott F Sieg, Michael M Lederman.   

Abstract

The mechanisms responsible for increased cardiovascular risk associated with HIV-1 infection are incompletely defined. Using flow cytometry, in the present study, we examined activation phenotypes of monocyte subpopulations in patients with HIV-1 infection or acute coronary syndrome to find common cellular profiles. Nonclassic (CD14(+)CD16(++)) and intermediate (CD14(++)CD16(+)) monocytes are proportionally increased and express high levels of tissue factor and CD62P in HIV-1 infection. These proportions are related to viremia, T-cell activation, and plasma levels of IL-6. In vitro exposure of whole blood samples from uninfected control donors to lipopolysaccharide increased surface tissue factor expression on all monocyte subsets, but exposure to HIV-1 resulted in activation only of nonclassic monocytes. Remarkably, the profile of monocyte activation in uncontrolled HIV-1 disease mirrors that of acute coronary syndrome in uninfected persons. Therefore, drivers of immune activation and inflammation in HIV-1 disease may alter monocyte subpopulations and activation phenotype, contributing to a pro-atherothrombotic state that may drive cardiovascular risk in HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23065151      PMCID: PMC3512236          DOI: 10.1182/blood-2012-05-433946

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  54 in total

Review 1.  Toll-like receptors and their ligands.

Authors:  G M Barton; R Medzhitov
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

2.  The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population.

Authors:  Manuela Rossol; Stephan Kraus; Matthias Pierer; Christoph Baerwald; Ulf Wagner
Journal:  Arthritis Rheum       Date:  2012-03

3.  The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF.

Authors:  Kai-Uwe Belge; Farshid Dayyani; Alexia Horelt; Maciej Siedlar; Marion Frankenberger; Bernhard Frankenberger; Terje Espevik; Löms Ziegler-Heitbrock
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

Review 4.  Immune mechanisms in atherosclerosis.

Authors:  G K Hansson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-12       Impact factor: 8.311

5.  CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis.

Authors:  Norikuni Kawanaka; Masahiro Yamamura; Tetsushi Aita; Yoshitaka Morita; Akira Okamoto; Masanori Kawashima; Mitsuhiro Iwahashi; Akiko Ueno; Yasukazu Ohmoto; Hirofumi Makino
Journal:  Arthritis Rheum       Date:  2002-10

6.  Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes.

Authors:  G Liuzzo; J J Goronzy; H Yang; S L Kopecky; D R Holmes; R L Frye; C M Weyand
Journal:  Circulation       Date:  2000-06-27       Impact factor: 29.690

Review 7.  Atherosclerosis and HIV in the highly active antiretroviral therapy era: towards an epidemic of cardiovascular disease?

Authors:  Vincent Mooser
Journal:  AIDS       Date:  2003-04       Impact factor: 4.177

8.  Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection.

Authors:  Priscilla Y Hsue; Kamini Giri; Sara Erickson; John S MacGregor; Naji Younes; Amandeep Shergill; David D Waters
Journal:  Circulation       Date:  2004-01-12       Impact factor: 29.690

9.  CD14 is an acute-phase protein.

Authors:  Sylvette Bas; Benoit R Gauthier; Ursula Spenato; Sybille Stingelin; Cem Gabay
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

10.  Fractalkine preferentially mediates arrest and migration of CD16+ monocytes.

Authors:  Petronela Ancuta; Ravi Rao; Ashlee Moses; Andrew Mehle; Sunil K Shaw; F William Luscinskas; Dana Gabuzda
Journal:  J Exp Med       Date:  2003-06-16       Impact factor: 14.307

View more
  128 in total

Review 1.  Sex as a Biological Variable in Atherosclerosis.

Authors:  Joshua J Man; Joshua A Beckman; Iris Z Jaffe
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

2.  Anaemia is associated with monocyte activation in HIV-infected adults on antiretroviral therapy.

Authors:  Hannah M Lipshultz; Corrilynn O Hileman; Sanjay Ahuja; Nicholas T Funderburg; Grace A McComsey
Journal:  Antivir Ther       Date:  2015-02-10

3.  Direct Targeting of Macrophages With Methylglyoxal-Bis-Guanylhydrazone Decreases SIV-Associated Cardiovascular Inflammation and Pathology.

Authors:  Joshua A Walker; Andrew D Miller; Tricia H Burdo; Michael S McGrath; Kenneth C Williams
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-15       Impact factor: 3.731

4.  Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s.

Authors:  Theodoros Kelesidis; Thuy Tien T Tran; James H Stein; Todd T Brown; Carlee Moser; Heather J Ribaudo; Michael P Dube; Robert Murphy; Otto O Yang; Judith S Currier; Grace A McComsey
Journal:  Clin Infect Dis       Date:  2015-04-22       Impact factor: 9.079

5.  Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation.

Authors:  David A Zidar; Steven Juchnowski; Brian Ferrari; Brian Clagett; Heather A Pilch-Cooper; Shawn Rose; Benigno Rodriguez; Grace A McComsey; Scott F Sieg; Nehal N Mehta; Michael M Lederman; Nicholas T Funderburg
Journal:  J Acquir Immune Defic Syndr       Date:  2015-06-01       Impact factor: 3.731

Review 6.  Inflammation, immune activation, and cardiovascular disease in HIV.

Authors:  Eric Nou; Janet Lo; Steven K Grinspoon
Journal:  AIDS       Date:  2016-06-19       Impact factor: 4.177

7.  Reduced CD14 expression on classical monocytes and vascular endothelial adhesion markers independently associate with carotid artery intima media thickness in chronically HIV-1 infected adults on virologically suppressive anti-retroviral therapy.

Authors:  Jason D Barbour; Emilie C Jalbert; Dominic C Chow; Louie Mar A Gangcuangco; Philip J Norris; Sheila M Keating; John Heitman; Lorna Nagamine; Todd Seto; Lishomwa C Ndhlovu; Beau K Nakamoto; Howard N Hodis; Nisha I Parikh; Cecilia M Shikuma
Journal:  Atherosclerosis       Date:  2013-10-31       Impact factor: 5.162

8.  Coagulation and morbidity in treated HIV infection.

Authors:  Nicholas T Funderburg; Michael M Lederman
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

Review 9.  Risk of coronary heart disease in patients with HIV infection.

Authors:  Markella V Zanni; Judith Schouten; Steven K Grinspoon; Peter Reiss
Journal:  Nat Rev Cardiol       Date:  2014-10-21       Impact factor: 32.419

10.  Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection.

Authors:  Eleanor M P Wilson; Amrit Singh; Katherine Huppler Hullsiek; Dave Gibson; W Keith Henry; Ken Lichtenstein; Nur F Önen; Erna Kojic; Pragna Patel; John T Brooks; Irini Sereti; Jason V Baker
Journal:  J Infect Dis       Date:  2014-05-09       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.